AstraZeneca to acquire Amolyt Pharma
Acquisition to further expand the Alexion, AstraZeneca Rare Disease pipeline beyond complement inhibition
Acquisition to further expand the Alexion, AstraZeneca Rare Disease pipeline beyond complement inhibition
Net product sales in the fourth quarter of 2023 include the recognition of $0.6 billion from deferred revenue, related to Gavi, the Vaccine Alliance
He is a former Neurology faculty member at The Johns Hopkins Hospital and an elected Fellow of the Royal College of Physicians, United Kingdom
GMP certification helps enable biotechnology customers to accelerate accessibility of new RNA-based therapies for patients
Acquisition underscores Merck’s ongoing commitment to developing treatments for neurodegenerative diseases
Patients Treated with ARIKAYCE plus macrolide-based background regimen had meaningfully larger improvements in QOL-B respiratory score
First clinical trial reporting results of an mRNA therapeutic for intracellular protein replacement
Sunrise is built on four elements i.e., Awareness, Screening & Diagnosis, Treatment, and Maintenance Support
The news on a shift in its focus comes after the refinement of Bayer’s early innovation framework
Apollo continues to invest in genomics technology and research for better patient care
Subscribe To Our Newsletter & Stay Updated